SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-066246
Filing Date
2023-08-11
Accepted
2023-08-11 16:15:27
Documents
52
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0623_hoththerap.htm   iXBRL 10-Q 506213
2 CERTIFICATION f10q0623ex31-1_hoththerap.htm EX-31.1 10432
3 CERTIFICATION f10q0623ex31-2_hoththerap.htm EX-31.2 10831
4 CERTIFICATION f10q0623ex32-1_hoththerap.htm EX-32.1 3629
5 CERTIFICATION f10q0623ex32-2_hoththerap.htm EX-32.2 3773
  Complete submission text file 0001213900-23-066246.txt   3392010

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE hoth-20230630.xsd EX-101.SCH 45459
7 XBRL CALCULATION FILE hoth-20230630_cal.xml EX-101.CAL 23644
8 XBRL DEFINITION FILE hoth-20230630_def.xml EX-101.DEF 182079
9 XBRL LABEL FILE hoth-20230630_lab.xml EX-101.LAB 379217
10 XBRL PRESENTATION FILE hoth-20230630_pre.xml EX-101.PRE 196814
46 EXTRACTED XBRL INSTANCE DOCUMENT f10q0623_hoththerap_htm.xml XML 344927
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38803 | Film No.: 231164298
SIC: 2834 Pharmaceutical Preparations